The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This pilot project is a randomized controlled trial where induced patients receive an
intervention of oxytocin discontinuation once in the active stage of labor (≥6 cm dilation).
The intent is to reduce uterine hyperstimulation and fetal distress, therefore, lowering
cesarean sections (CS) in first time mothers at term (≥ 37 weeks), with a cephalic presenting
singleton fetus, without increasing maternal or neonatal morbidity. If REDUCE-I pilot trial
suggests a safe reduction in CS rates and patient satisfaction, application for a
multi-centre randomized controlled trial would follow.